Literature DB >> 6674520

[Evaluation of fosfomycin in Campylobacter jejuni enteritis].

T Fuchigami, A Ootaki, Y Fujita, A Yoza, S Ryo, N Nishiyama.   

Abstract

Out of 1,219 pediatric patients who were brought to our hospital with chief complaint of diarrhea and abdominal pain and in whom stool cultures were obtained for bacteriological studies in the 17 month period from May 1 in 1981 to September 30 in 1982, Campylobacter jejuni was isolated in 203 patients (16.7%). In this study we assessed the efficacy of fosfomycin (FOM) for C. jejuni enteritis. Results of antibiotic susceptibility tests revealed that C. jejuni is highly sensitive to FOM. The efficacy of FOM was confirmed both clinically and bacteriologically. Moreover, improvement in diarrheal symptoms and the duration required for cultural conversion under FOM treatment were assessed. From the results obtained, it was considered that FOM is an antibiotic with high efficacy for the treatment of C. jejuni enteritis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6674520

Source DB:  PubMed          Journal:  Jpn J Antibiot        ISSN: 0368-2781


  2 in total

1.  Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; María Nieves Larrosa; Virginia Rodríguez-Garrido; Denisse Sihuay-Diburga; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds.

Authors:  Bai Wei; Min Kang
Journal:  PLoS One       Date:  2018-07-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.